A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU

NCT07552012 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Non-anterior, Non-infectious Uveitis

Interventions

OTHER: FXS5626 tablet
OTHER: FXS5626 tablet
OTHER: Placebo

Sponsor

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.